RBT-9

• UNSPSC Description:

  RBT-9 prevents progression to severe COVID-19 and organ failure. RBT-9 also has antiviral effects, as demonstrated in several enveloped viruses, including influenza, HCV, dengue, and yellow fever[1].

• Target Antigen:

  HCV; SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/rbt-9.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(CCC1=C(C)C2=[N]3C1=CC4=C(CCC(O)=O)C(C)=C5C=C6C(C=C)=C(C)C7=[N]6[Sn+2]3([N-]54)[N-]8C(C(C=C)=C(C)C8=C2)=C7)O

• Molecular Weight:

  679.35

• References & Citations:

  [1]S Ruiz, et al. Design of prevent: A phase 2 study of the effect of rbt-9 on progression of COVID-19 infection in high-risk individuals, including those with advanced ckd.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 2

• CAS Number:

  123307-75-5